Fig. 5
Exogenous expression of miR-101 reduces the migration of Hep-2 cells. Cell migration assays were performed 72 h after transduction using Boyden chambers coated with Matrigel. Fewer Hep-2 cells in the miR-101-treated group (c) migrated to the lower chambers of the transwell plates compared with the Hep-2 cells in the blank control group (a) and the Hep-2 cells in the negative control group (b). d Quantitation of the migration data ± SD is shown (*P < 0.05).